All Wuhan Institute of Virology articles
-
NewsHarnessing big data helps scientists hone in on new antimicrobials
Scientists have detailed a new method of identifying antimicrobial enzymes from large datasets of bacterial proteins, which could provide a solution to antibiotic resistance.
-
NewsNasal spray with antibodies could prevent COVID-19
Researchers have shown that nasal drops with IgA antibodies can protect mice from SARS-CoV-2 infection.
-
OpinionThe threat of viral zoonosis hasn’t gone away
Why we’re liable to be ambushed by viral zoonosis - despite everything we’ve learned from Covid
-
NewsTwo Chinese anti-SARS-CoV-2 drugs conditionally approved for marketing
Two innovative Chinese oral anti-SARS-CoV-2 drugs, Xiannuoxin (simnotrelvir/ritonavir) and VV116 (deuremidevir hydrobromide), were conditionally approved for marketing by China’s National Medical Products Administration (NMPA) in late January after urgent review and approval under the Special Examination and Approval of Drugs Policy.
